Literature DB >> 721136

Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.

J Hamuro, U Hadding, D Bitter-Suermann.   

Abstract

The efficiency of some anti-tumour polysaccharides, such as lentinan, pachyman, pachymaran, carboxymethylpachymaran and hydroxyethylpachyman to trigger the alternative pathway of complement activation (APC) was investigated in detail, in order to clarify whether solid phase activation of APC by these polysaccharides will occur or not. From the eight polysaccharides tested, all were found to be potent activators of the alternative pathway except for carboxymethylpachymaran, regardless of their potency of inhibition of sarcoma 180 (S 180) transplanted in mice. This activation was observed both for the insoluble as well as the soluble part of the same polysaccharide. The turnover of C3, C5 and factor B showed no difference among these seven active polysaccharides. The polysaccharide particles (PX), isolated after treatment with C4d GPS showed prominent C3 consuming activity, which disappeared during prolonged incubation at 37 degrees. The activity of the decayed enzyme could be regenerated by treatment with the purified factor B. The stability of the particulate enzyme PX was comparable to the zymosan-complex (ZX) previously described.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 721136      PMCID: PMC1457186     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.

Authors:  L PILLEMER; M D SCHOENBERG; L BLUM; L WURZ
Journal:  Science       Date:  1955-09-23       Impact factor: 47.728

2.  Mouse factor B of the alternative pathway of complement activation. I. Purification, characterization, and functional behavior.

Authors:  D Bitter-Suermann; R Burger; V Brade; U Hadding
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

3.  Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation.

Authors:  U Hadding; M Dierich; W König; M Limbert; H U Schorlemmer; D Bitter-Suermann
Journal:  Eur J Immunol       Date:  1973-08       Impact factor: 5.532

4.  Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.

Authors:  V Brade; A Nicholson; D Bitter-Suermann; U Hadding
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

5.  On the mode of action of BCG.

Authors:  M S Mitchell; D Kirkpatrick; M B Mokyr; I Gery
Journal:  Nat New Biol       Date:  1973-06-13

6.  Antitumor polysaccharide derived chemically from natural glucan (pachyman).

Authors:  G Chihara; J Hamuro; Y Maeda; Y Arai; F Fukuoka
Journal:  Nature       Date:  1970-03-07       Impact factor: 49.962

7.  Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom).

Authors:  G Chihara; J Hamuro; Y Maeda; Y Arai; F Fukuoka
Journal:  Cancer Res       Date:  1970-11       Impact factor: 12.701

8.  Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.

Authors:  D Bitter-Suermann; M Dierich; W König; U Hadding
Journal:  Immunology       Date:  1972-09       Impact factor: 7.397

9.  A molecular concept of the properdin pathway.

Authors:  R G Medicus; R D Schreiber; O Götze; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

10.  Activation of the alternative complement pathway by water-insoluble glucans of streptococcus mutans: the relation between their chemical structures and activating potencies.

Authors:  S Inal; K Nagaki; S Ebisu; K Kato; S Kotani
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

View more
  9 in total

1.  The effect of lentinan on the resistance of mice to Mesocestoides corti.

Authors:  T R White; R C Thompson; W J Penhale; G Chihara
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

2.  Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.

Authors:  Gayle M Boxx; Thomas R Kozel; Casey T Nishiya; Mason X Zhang
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

3.  Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis.

Authors:  J K Czop; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Glucan as an adjuvant for a murine Babesia microti immunization trial.

Authors:  J L Benach; G S Habicht; T W Holbrook; J A Cook
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

5.  Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis.

Authors:  T Miyazaki; S Kohno; K Mitsutake; S Maesaki; K Tanaka; N Ishikawa; K Hara
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 6.  Antiinflammatory and immunomodulating properties of fungal metabolites.

Authors:  Cristina Lull; Harry J Wichers; Huub F J Savelkoul
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

7.  Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil.

Authors:  Naho Maruyama; Yuka Sekimoto; Hiroko Ishibashi; Shigeharu Inouye; Haruyuki Oshima; Hideyo Yamaguchi; Shigeru Abe
Journal:  J Inflamm (Lond)       Date:  2005-02-10       Impact factor: 4.981

Review 8.  The use of lentinan for treating gastric cancer.

Authors:  Kenji Ina; Takae Kataoka; Takafumi Ando
Journal:  Anticancer Agents Med Chem       Date:  2013-06       Impact factor: 2.505

9.  Immune stimulating properties of a novel polysaccharide from the medicinal plant Tinospora cordifolia.

Authors:  P K Raveendran Nair; Sonia Rodriguez; Reshma Ramachandran; Arturo Alamo; Steven J Melnick; Enrique Escalon; Pedro I Garcia; Stanislaw F Wnuk; Cheppail Ramachandran
Journal:  Int Immunopharmacol       Date:  2004-12-15       Impact factor: 4.932

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.